Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors

Authors :: Bjornhart, B.
Mouritzen, M.
Kristiansen, C.
Holmskov, K. H.
Wedervang, K.
Jorgensen, T. L.
Herrstedt, J.
Pohl, M.
Schytte, T.
Source :: Bjornhart, B, Mouritzen, M, Kristiansen, C, Holmskov, K H, Wedervang, K, Jorgensen, T L, Herrstedt, J, Pohl, M & Schytte, T 2022, ' Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors ', Annals of Oncology, vol. 33, no. Suppl. 7, 1114P, pp. S1060 . https://doi.org/10.1016/j.annonc.2022.07.1239
Publication Year :: 2022

Language :: English
Database :: OpenAIRE
Journal :: Bjornhart, B, Mouritzen, M, Kristiansen, C, Holmskov, K H, Wedervang, K, Jorgensen, T L, Herrstedt, J, Pohl, M & Schytte, T 2022, ' Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors ', Annals of Oncology, vol. 33, no. Suppl. 7, 1114P, pp. S1060 . https://doi.org/10.1016/j.annonc.2022.07.1239
Accession number :: edsair.dedup.wf.001..5efebd677904584acfb7e60d015ad198

Tools